Related Experiment Video
Updated: Nov 6, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Contamination: How much can an individually randomized trial tolerate?
Karla Hemming1, Monica Taljaard2, Mirjam Moerbeek3
1Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
Abstract:
Cluster randomization results in an increase in sample size compared to individual randomization, referred to as an efficiency loss. This efficiency loss is typically presented under an assumption of no contamination in the individually randomized trial. An alternative comparator is the sample size needed under individual randomization to detect the attenuated treatment effect due to contamination. A general framework is provided for determining the extent of contamination that can be tolerated in an individually randomized trial before a cluster randomized design yields a larger sample size. Results are presented for a variety of cluster trial designs including parallel arm, stepped-wedge and cluster crossover trials. Results reinforce what is expected: individually randomized trials can tolerate a surprisingly large amount of contamination before they become less efficient than cluster designs. We determine the point at which the contamination means an individual randomized design to detect an attenuated effect requires a larger sample size than cluster randomization under a nonattenuated effect. This critical rate is a simple function of the design effect for clustering and the design effect for multiple periods as well as design effects for stratification or repeated measures under individual randomization. These findings are important for pragmatic comparisons between a novel treatment and usual care as any bias due to contamination will only attenuate the true treatment effect. This is a bias that operates in a predictable direction. Yet, cluster randomized designs with post-randomization recruitment without blinding, are at high risk of bias due to the differential recruitment across treatment arms. This sort of bias operates in an unpredictable direction. Thus, with knowledge that cluster randomized trials are generally at a greater risk of biases that can operate in a nonpredictable direction, results presented here suggest that even in situations where there is a risk of contamination, individual randomization might still be the design of choice.
Insights
Individual randomization may still be preferred over cluster randomization, even with contamination. Individually randomized trials can tolerate significant contamination before cluster designs become more efficient.
Area of Science:
- Clinical Trial Design
- Biostatistics
- Epidemiology
Background:
- Cluster randomization often requires larger sample sizes than individual randomization due to efficiency loss.
- Contamination, where treatment effects spill over between participants, complicates sample size calculations in individually randomized trials.
- Existing comparisons typically assume no contamination in individually randomized trials.
Purpose of the Study:
- To develop a framework for determining the tolerable level of contamination in individually randomized trials before cluster randomization becomes more sample-size efficient.
- To compare sample size requirements between individually randomized and cluster randomized designs under varying degrees of contamination.
Main Methods:
- Developed a general framework to calculate the critical contamination rate.
- Analyzed various cluster trial designs: parallel-arm, stepped-wedge, and cluster crossover.
- Calculated sample size needs for individually randomized trials detecting attenuated effects versus cluster randomized trials with non-attenuated effects.
Main Results:
- Individually randomized trials can tolerate substantial contamination before cluster designs require a larger sample size.
- The critical contamination rate is a function of design effects for clustering, multiple periods, stratification, and repeated measures.
- Cluster randomized designs carry a higher risk of unpredictable bias due to differential recruitment without blinding.
Conclusions:
- Despite contamination risks, individual randomization may remain the preferred design choice due to its lower risk of unpredictable bias compared to cluster designs.
- The findings are crucial for pragmatic trial comparisons, especially when contamination predictably attenuates treatment effects.
More Related Videos
Related Concept Videos
Randomized Experiments
Simple randomization
Simple...
Blinding
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Censoring Survival Data
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Controls in Experiments

